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Background: Reports detailing microscopic observations of indocyanine green (ICG) fluorescence imaging (IFI) in
hepatocellular carcinoma (HCC) and metastatic liver cancer are rare. We were able to perform macro- and microscopic
IFI results in postoperative paraffin-embedded tissue samples and formalin-fixed specimens from liver tumors.
Methods: Between April 2010 and March 2014, 19 patients with HCC or liver metastases of colorectal tumors
underwent liver resection. ICG solution was injected into the peripheral vein from 14 to 2 days prior to operation. We
observed liver tumor IFI during the laparotomy and IFI in resected liver sections using a photo dynamic emission (PDE)
camera. The IFI of paraffin-embedded tissue samples was observed using a charge-coupled device (CCD) camera.
Moreover, we microscopically performed tissue section IFI using a fluorescence microscope with an ICG-B-NQF.
Results: We performed that IFI characteristics depended on tumor type macroscopically and microscopically. In normal
liver tissue, fluorescence consistent with the bile canaliculus was observed. HCC had heterogeneous IFI, forming a total
or partial tumor and rim pattern. In metastatic carcinoma, we performed that non-tumor cells in the marginal region
showed fluorescence and tumor cells in the central region did not fluoresce.
Conclusions: We confirmed that the variations of ICG fluorescence imaging patterns reflect different tumor
characteristics in not only macroscopic imaging as previous reports but also microscopic imaging. Moreover, the ICG
fluorescence method is useful for postoperative pathological detection of microscopic lesions in histopathological
specimens. ICG fluorescence in paraffin-embedded tissue samples and formalin-fixed specimens is preserved in the
long term.
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Indocyanine green (ICG) combines with serum proteins
in vivo and produces a fluorescence signal [1]. ICG
fluorescence imaging (IFI) is increasingly being used in
fluorescence-guided surgery, i.e., in breast [2], gastric [3,
4], and esophageal cancer [5] surgeries and vascular sur-
gery [6]. Applications of IFI, including tattooing of liver
segments [7, 8] and providing biliary tract contrast [9],
have been reported in the liver surgery field. Some insti-
tutions have recently reported IFI macroscopic features
in hepatocellular carcinoma (HCC) and metastatic liver
tumors [10–13]. Liver tumors can be observed using
fluorescence imaging and generally have heterogeneous* Correspondence: shingoshimada1979@true.ocn.ne.jp
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In contrast, metastatic liver tumors have a corona-like
fluorescence pattern in the marginal region of the tumor
[10, 12, 13]. Generally, IFI can be used for intraoperative
tumor detection. However, there are few reports focused
on postoperative IFI samples. Particularly, reports detail-
ing microscopic IFI observations in HCC and metastatic
liver tumors are rare.
In this study, we performed macro- and microscopic
IFI characteristics in liver tumors using postoperative
paraffin-embedded tissue and formalin-fixed specimens.Methods
Between April 2010 and March 2014, 19 patients with
liver tumors underwent liver resection at the Japan
Labor Health and Welfare Organization, Kushiro Rosai
Hospital, Department of Surgery in Kushiro, Japan. Thisarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Kushiro Rosai Hospital and performed according to the
Helsinki Declaration guidelines. The clinicopathological
characteristics and surgical data of the patients are
shown in Table 1.
ICG solution was injected into the peripheral vein
from 14 to 2 days prior to the operation.
To evaluate the liver tissue, we also performed intra-
operative ICG injection in several cases.
The ICG injection dose was 0.5 mg/kg. We observed
the liver tumor IFI during the laparotomy and IFI in
resected liver sections using a photo dynamic emission
(PDE) camera (Hamamatsu Photonics, Hamamatsu).
The IFI of paraffin-embedded tissue was obtained using
a charge-coupled device (CCD) camera with a light-
emitting diode at a 760-nm wavelength as the light emit-
ter and a cut filter to filter light at wavelengths below
820 nm as the detector. Moreover, we microscopically
observed tissue section IFI using a fluorescence micro-
scope with an ICG-B-NQF (OPTO-LINE, Tokyo).
Results
Clinicopathological characteristics
A total of 19 patients were observed in this study. Of
these patients, 12 patients had hepatocellular carcinoma,
while seven patients had liver metastases of colorectal
cancer (CRC). In HCC patients, the numbers of males
and females were eight and four, respectively. Two cases
were well differentiated, four cases had moderate differ-
entiation and five cases had poor differentiation. One
case had unknown differentiation. Four cases had partial
resections performed, five cases had liver subsegmentec-
tomies performed, two cases had liver segmentectomies
performed, and one case had a hepatic lobectomy per-
formed. Two cases had normal livers (NL), one case had
chronic hepatitis (CH), four cases had liver fibrosis (LF),
and five cases had liver cirrhosis (LC). In case No. 10, we
were able to detect and resect by using IFI the main tumor
and also small metastases, which were not identified with
the preoperative imaging. In metastatic liver tumor cases,
all patients were male and had partial resections per-
formed. All cases had no cirrhosis or fibrosis (Table 1).
Intraoperative observation
We were able to detect the targeted tumor by using IFI in
all cases (Table 1). In the majority of cases, we were able
to observe the whole tumor fluorescence (Fig. 1a), except
in three cases with metastatic tumors derived from CRC
that had rim fluorescence (Fig. 1b). Normal livers (non-
cancerous sections) had uniform fluorescence after intra-
operative ICG injection (Fig. 1c) while cirrhotic livers
(non-cancerous sections) had heterogeneous fluorescence
where the regenerated nodule strongly fluoresced (Fig. 1d).
After ICG injection, we observed immediate emission andearly washout in the normal liver. Conversely, we ob-
served late emission and late washout in the cirrhotic liver
as an aggravation of cirrhosis.
Postoperative observation of liver sections
Six HCC cases had total tumor fluorescence emission
(total tumor type), four cases had partial tumor fluores-
cence emission (partial tumor type), and two cases had
rim-like fluorescence (rim type) in the liver sections
(Table 1). All cases of well- or moderately differentiated
tumors had total tumor type fluorescence (Fig. 2a). In
five cases with poorly differentiated HCC, there were no
tumors with total tumor type fluorescence, four cases
with partial tumor type fluorescence (Fig. 2b), and one
case (case 9) with rim type fluorescence (Fig. 2c). Case
12, which had an unknown HCC differentiation classifi-
cation, had rim type fluorescence (Fig. 2d).
In cases of metastatic liver tumors derived from CRC,
all cases had rim-like fluorescence at the marginal region
of the tumor in the liver sections (Table 1) (Fig. 2e).
Observations in paraffin-embedded tissue
ICG fluorescence was not limited to fresh tissues but
was also observable in paraffin sections (Fig. 3a–e). In
the paraffin-embedded tissue samples, almost all cases
had the same results as the sections; however, cases 7, 8,
and 11 had different results compared with the liver sec-
tions. These samples had the rim type of IFI (Table 2).
We were able to observe tumor fluorescence in sam-
ples that were obtained 3 years and 8 months earlier in
the paraffin-embedded tissue samples.
Microscopic findings
Hepatocytes from cirrhotic livers had stronger IFI values
than those from non-cirrhotic livers. While hepatocyte IFI
values in non-cirrhotic livers were weaker than cirrhotic
livers, the IFI values in the bile canaliculus in non-cirrhotic
livers were higher than those in cirrhotic livers (Fig. 4a, b).
In hepatocellular carcinoma cases, tumor cells had
heterogeneous fluorescence. Total or partial HCC tumor
type paraffin-embedded tissue samples had cytoplasmic
fluorescence as observed by ICG fluorescence micros-
copy (Fig. 4c, d). Furthermore, some HCC cases that had
rim IFI had nuclear IFI in cancer cells and cytoplasmic
IFI in the surrounding non-cancer cells (Fig. 4e, f ).
Metastatic cancers that had the rim type had cytoplas-
mic ICG fluorescence in non-cancer cells surrounding
cancer cells (Table 2) (Fig. 4g).
Discussion
In this study, we were able to perform the macroscopic
and microscopic characteristics of different tumor types
by using ICG fluorescence imaging (IFI). In normal hepa-
tocytes, fluorescence consistent with the bile canaliculus
Table 1 Clinicopathological characteristics and macroscopic observations of IFI
Case Age Sex Diagnosis Location Size (cm) Number ICGR15
(%)
AFP PIVKA-II CEA CA19-9 Operation Pathology and
differentiation






1 66 F HCC S6 3 × 3 1 11.0 2.2 16 NA NA Subsegmentectomy Hepatocellular
carcinoma—well




2 79 F HCC S8 2 × 2 1 18.9 18.7 18 NA NA Subsegmentectomy Hepatocellular
carcinoma—well












4 49 M HCC S7 1.5 × 1.4 1 7.9 32.9 25 NA NA Subsegmentectomy Hepatocellular
carcinoma—mod
0 0 1 LC Total tumor Total,
heterogeneously
5 54 M HCC S7/8 3 × 3 1 14.7 90.8 95 4.2 0.2 Partial resection Hepatocellular
carcinoma—mod




6 75 M HCC S8 2 × 2 1 17.3 1951.2 19 NA NA Partial resection Hepatocellular
carcinoma—mod




7 80 F HCC S4 4.5 × 4.5 1 18.3 NA 6087 NA NA Partial resection Hepatocellular
carcinoma—por












9 65 M HCC S7 1.5 × 1.5 1 11.7 2.7 42 4.5 NA Partial resection Hepatocellular
carcinoma—por
0 0 0 LF Total
tumor
Rim
10 74 M HCC S5 6 × 6 1 8.2 6.4 83 2.1 3.9 Subsegmentectomy Hepatocellular
carcinoma—por




11 61 M HCC S8 1.4 × 1.4 1 9.9 45.5 23 NA NA Subsegmentectomy Hepatocellular
carcinoma—por




12 32 F HCC S5/6/7/8 15 × 12 1 7.0 1006.6 108 2.7 541.4 Right lobectomy Hepatocellular
carcinoma—unknown
0 0 0 NL Total
tumor
Rim
13 66 M Metastasis
of CRC
S6 2.5 × 2.5 1 16.1 NA NA 2.7 6.3 Subsegmentectomy Adenocarcinoma—mod NA NA NA NL Total
tumor
Rim
14 70 M Metastasis
of CRC
S6 2.5 × 2.5 1 11.5 NA NA 3.1 2.2 Partial resection Adenocarcinoma—mod NA NA NA NL Rim Rim
15 72 M Metastasis
of CRC
S5/8 4 × 4 1 9.7 4.1 17 6.6 8.9 Partial resection Adenocarcinoma—mod NA NA NA NL Rim Rim
16 58 M Metastasis
of CRC
S6 0.8 × 0.8 1 16.0 NA NA 2.4 44 Posterior
segmentectomy
Adenocarcinoma—mod NA NA NA NL Total
tumor
Rim
17 45 M Metastasis
of CRC
S3 2.3 × 1.6 1 16.3 NA NA 1.5 7 Lateral
segmentectomy
Adenocarcinoma—mod NA NA NA NL Total
tumor
Rim
18 74 M Metastasis
of CRC
S6 1.5 × 1.5 1 5.0 3.9 NA 2.6 2.2 Partial resection Adenocarcinoma—mod NA NA NA NL Rim Rim
19 66 M Metastasis
of CRC
S3, S4, S8 S3 4.8 × 4.5,
S4 4.6 × 4.5,
S8 1.7 × 1.5
3 19.1 NA NA 7 886.6 Left lobectomy,
partial resection
















Fig. 1 Intraoperative ICG fluorescence imaging (IFI). a Total tumor type (case 6). b Rim type (case 14). c Normal livers (non-cancerous part) had
uniform fluorescence after intraoperative ICG injection (case 3). d Cirrhotic livers (non-cancerous part) had heterogeneous fluorescence, and the
regenerated nodule was strongly fluorescent (case 5)
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heterogeneous and exhibited various patterns. In meta-
static carcinoma, we observed that non-tumor cells in the
marginal region showed fluorescence and tumor cells in
the central region did not fluoresce.
ICG is generally used as a liver function assay [14].
Moreover, ICG, which is approved by the Food and Drug
Administration, is safe and comparatively economical.Fig. 2 Postoperative observation of liver specimen sections. a Total tumor
type (case 12). e Rim type (case 14)ICG combines with serum proteins in vivo and fluo-
resces under excitation at 760–820 nm [1].
In animal experiments, ICG that was injected into the
peripheral vein accumulated in the liver [15] demon-
strating that ICG has a high affinity for the liver.
Within the liver surgery field, ICG fluorescence im-
aging applications have been reported for the detection
of HCC or metastases derived from CRC [10, 11, 13]type (case 5). b Partial tumor type (case 10). c Rim type (case 9). d Rim
Fig. 3 ICG fluorescence imaging (IFI) of paraffin-embedded tissue samples. ICG fluorescence was present in paraffin-embedded tissue samples.
a Total tumor type (case 5). b Partial tumor type (case 10). c Rim type (case 9). d Rim type (case 12). e Rim type (case 14)
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ment [7, 8], detection of biliary leakage [16, 17], and
evaluation of hepatic congested areas [18] and vascular
flow [19] after liver transplantation via contrast of the
biliary tract. OATP1B3 and Na+ taurocholate cotran-
sporting polypeptide (NTCP) have been demonstrated
to transport ICG [20]. Eisai rats that lack functional
MRP2 revealed that biliary ICG excretion is mediated by
MRP2 [21].
Ishizawa et al. reported that well- or moderately differ-
entiated HCC mostly displayed uniform or partial type
fluorescence, poorly differentiated HCC mostly displayed
rim type fluorescence, and metastatic tumors mostly dis-
played rim type fluorescence [10] in part because the de-
gree of NTCP and OATP8 expression varied according
to tumor differentiation [22]. Moreover, it was reported
that there was a high false positive tumor detection rate
in cirrhotic livers by using ICG fluorescence imaging
[23]. In this study, these transporters were not evaluated,
but the ICG fluorescence observations may be related to
these transporters.
In this study, most tumors, particularly HCC tumors,
appeared to be total tumor type from superficial obser-
vation. However, some cases had discrepancies between
superficial observations and sectional observations.
All cases where the superficial observations were con-
sistent with the sectional observations, except for the total
tumor type, were cases where the tumor was exposed on
the hepatic surface.
Although we observed that many IFI had total type
fluorescence from the surface view, some tumor sectionshad partial or rim IFI. We believe that the IFI discrep-
ancy between the surface and sections may be present in
cases where the tumor is located far from the surface,
resulting in unclear total IFI.
We observed consistent results between sections and
paraffin-embedded tissues in most cases, including all
metastatic tumor cases. However, the results were not
consistent in three HCC cases. All these cases had
poorly differentiated HCC. Poorly differentiated HCC
cases had more variation in IFI results, i.e., the partial
type or rim type, in comparison with well- and moder-
ately differentiated HCC.
This result was consistent in sections and paraffin-
embedded tissues. We believe that the cause of the dis-
crepancy between sections and paraffin-embedded tissues
is IFI tumor heterogeneity.
This would suggest that IFI tumor heterogeneity in-
creases as tumor differentiation fall. We suggest that
ICG is excreted more slowly in less differentiated cancer
cells. ICG uptake and excretion differ depending on the
cancer cells, and we are able to perform this “heterogen-
eity” using a fluorescence microscope.
Ishizawa et al. reported that HCC of the total or par-
tial tumor type exhibited fluorescence within the cyto-
plasm and pseudoglands under ICG fluorescence
imaging. Additionally, HCC or metastatic cancer with
the rim type had ICG fluorescence in non-cancer cells
surrounding cancer cells [22]. They suggested that the
cause was the following: while ICG portal uptake ability
was preserved, biliary excretion ability was reduced in
differentiated HCC [22]. The biliary excretion ability of
Table 2 Paraffin block and microscopic observations of IFI
Case Age Sex Diagnosis Location Size (cm) Number Non-cancerous live IRI of paraffin block IRI of microscopy Time after operation
1 66 F HCC S6 3 × 3 1 LC Total, heterogeneously Cytosol of cancer cell 3 years, 8 months
2 79 F HCC S8 2 × 2 1 LF Total, heterogeneously Cytosol of cancer cell 2 years, 11 months
3 71 M HCC S6/7 8 × 8 2 NL Total, heterogeneously Cytosol of cancer cell 3 years, 4 months
4 49 M HCC S7 1.5 × 1.4 1 LC Total, heterogeneously Cytosol of cancer cell 3 years, 2 months
5 54 M HCC S7/8 3 × 3 1 LC Total, heterogeneously Cytosol of cancer cell 2 years, 9 months
6 75 M HCC S8 2 × 2 1 LF Total, heterogeneously Cytosol of cancer cell 1 year, 10 months
7 80 F HCC S4 4.5 × 4.5 1 CH Rim Nuclei of cancer cell and
cytosol of non-cancer cell
1 year, 2 months
8 78 M HCC S2/3 11 × 8 1 LF Rim Nuclei of cancer cell and
cytosol of non-cancer cell
3 years, 4 months
9 65 M HCC S7 1.5 × 1.5 1 LF Rim Nuclei of cancer cell and
cytosol of non-cancer cell
3 months
10 74 M HCC S5 6 × 6 1 LC Partial, heterogeneously Cytosol of cancer cell 2 years, 4 months
11 61 M HCC S8 1.4 × 1.4 1 LC Rim Nuclei of cancer cell and
cytosol of non-cancer cell
3 years, 7 months
12 32 F HCC S5/6/7/8 15 × 12 1 NL Rim Nuclei of cancer cell and
cytosol of non-cancer cell
9 months
13 66 M Metastasis of CRC S6 2.5 × 2.5 1 NL Rim Cytosol of cancer cell 3 years, 2 months
14 70 M Metastasis of CRC S6 2.5 × 2.5 1 NL Rim Cytosol of cancer cell 2 years, 4 months
15 72 M Metastasis of CRC S5/8 4 × 4 1 NL Rim Cytosol of cancer cell 1 year, 8 months
16 58 M Metastasis of CRC S6 0.8 × 0.8 1 NL Rim Cytosol of cancer cell 2 years, 2 months
17 45 M Metastasis of CRC S3 2.3 × 1.6 1 NL Rim Cytosol of cancer cell 1 year, 4 months
18 74 M Metastasis of CRC S6 1.5 × 1.5 1 NL Rim Cytosol of cancer cell 1 year, 3 months
19 66 M Metastasis of CRC S3, S4, S8 S3 4.8 × 4.5, S4 4.6 ×
4.5, S8 1.7 × 1.5














Fig. 4 Microscopic findings from ICG fluorescence imaging (IFI) in tissue sections by using a fluorescence microscope with an ICG-B-NQF and HE
staining of the adjacent section. a Normal liver; hepatocyte IFI was not strong; IFI in the bile canaliculus exhibited increased strength (case 3).
b Cirrhotic livers; hepatocytes had stronger IFI than normal livers (case 5). c IFI was observed in the cytoplasm of cancer cells (case 9). d IFI was
observed in the cytoplasm of cancer cells (case 4). e Tumor cells had heterogeneous fluorescence. We observed the IFI signal of cancer cells and
of non-cancer cells surrounding cancer cells (case 12). f Nuclear IFI signal in cancer cells was observed (case 12). g IFI existed in the cytoplasm of
non-cancer cells surrounding cancer cells (case 14)
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tumor in poorly differentiated HCC or metastatic cancer.
Consistent with these reports, in the present study, it
was observed that the total or partial tumor type of
HCC exhibited cytoplasmic fluorescence signal under
ICG fluorescence microscopy, and metastatic cancers
with the rim type exhibited ICG fluorescence in non-
cancer cells surrounding the cancer cells. In some cases
that exhibited rim IFI in poorly differentiated HCC or
HCC of unknown differentiation status, there was nu-
clear IFI signal in cancer cells and cytoplasmic IFI signal
in non-cancer cells surrounding the cancer cells.
Cancer cells may not fluoresce in metastatic liver can-
cer cases because cancer cells do not have the character-
istics of hepatocytes. Macroscopic observations between
metastatic liver cancer and HCC with the rim type werethe same; however, microscopic observations between
metastatic liver cancer and HCC with the rim type were
somewhat disparate. While cancer cells did not exhibit
IFI signal in metastatic liver cancers, the cancer cells ex-
hibited IFI signal in different regions in poorly differenti-
ated HCC or HCC of unknown differentiation status
compared with other types. The exact cause of this
phenomenon is elusive but may be related to the tumor
characteristics derived from differentiation. Further in-
vestigation is necessary to clarify these observations.
In non-cancerous liver tissue, hepatocytes in cirrhotic
livers had stronger IFI values than non-cirrhotic livers.
However, there were stronger IFI values in the bile cana-
liculus in non-cirrhotic livers than cirrhotic livers. This
result may be due to the early washout of ICG resulting
from the preserved ICG-excretion ability of hepatocytes.
Shimada et al. World Journal of Surgical Oncology  (2015) 13:198 Page 8 of 9After ICG injection, we observed immediate emission
and early washout in the normal liver. Conversely, we
observed late emission and late washout in cirrhotic
livers as an aggravation of cirrhosis. Therefore, the re-
generated nodule had an emission as strong as the
tumor. In certain instances, there may not be a differen-
tiation between the regenerated nodule and the tumor.
In this study, we successfully performed IFI at the cel-
lular level using fluorescence microscopy with an ICG-
B-NQF. This type of research is rare and is a useful
method for progressing ICG fluorescence method re-
search. However, the limitation of this study is the follow-
ing. The period from surgery to observation was different
about the paraffin blocks and microscopic sections be-
cause we retrospectively observed these samples. Then,
we could not compare fluorescence intensity between
three imaging techniques because the devices and condi-
tion between three imaging techniques were different.
In this study, we were able to observe fluorescence in a
paraffin-embedded tumor tissue sample that was obtained
more than 3 years earlier. Therefore, we can retrospect-
ively evaluate tumor fluorescence. For example, we could
retrospectively detect micro lesions in histopathological
specimens using the ICG fluorescence method. It has been
suggested that ICG, which is bound to intracellular pro-
teins, is preserved in paraffin-embedded tissue. However,
the precise mechanism of the ICG fluorescence retention
is elusive. We did not investigate the optimal conditions
for paraffin-embedded tissue to preserve fluorescence in-
tensity. Further study is necessary to define the optimal
conditions for preserving the fluorescence signal. How-
ever, we believe that discovering that ICG fluorescence in
paraffin-embedded tissue samples can be retrospectively
observed is very important.
Conclusions
We confirmed that the variations of ICG fluorescence im-
aging patterns reflect different tumor characteristics in not
only macroscopic imaging as previous reports [10, 22] but
also microscopic imaging. Moreover, the ICG fluorescence
method is also useful for postoperative pathological detec-
tion of micro lesions in histopathological specimens. ICG
fluorescence in paraffin-embedded tissue samples and
formalin-fixed specimens is preserved in the long term.
However, further investigations are needed to clarify the
reasons and optimal conditions for sample preservation.
Abbreviations
CCD: charge-coupled device; CH: chronic hepatitis; CRC: colorectal cancer;
HCC: hepatocellular carcinoma; ICG: indocyanine green; IFI: ICG fluorescence
imaging; LC: liver cirrhosis; LF: liver fibrosis; MRP2: multidrug resistance associated
protein 2; NL: normal liver; NTCP: Na+ taurocholate cotransporting polypeptide;
OATP: organic anion transporting polypeptide; PDE: photo dynamic emission.
Competing interests
All of the authors declare that they have no competing interests.Authors’ contributions
SS carried out the analysis of data and observation of the liver and wrote the
manuscript. SO provided the fluorescence microscope system. KO and MK
gave comments and revised the manuscript. All authors read and approved
the final manuscript.
Acknowledgements
The authors would like to thank the staff of the Department of Surgery of
the Japan Labor Health and Welfare, Kushiro Rosai Hospital, for their kind
cooperation.
Author details
1Department of Surgery, Japan Labor Health and Welfare Organization,
Kushiro Rosai Hospital, 13-12, Nakazono-cho, Kushiro, Hokkaido 085-8533,
Japan. 2Department of Oral and Maxillofacial Surgery, Japan Labor Health
and Welfare Organization, Kushiro Rosai Hospital, 13-12, Nakazono-cho,
Kushiro, Hokkaido 085-8533, Japan. 3Department of Surgery, Seiwa Memorial
Hospital, 1-5-1-1, Kotoni, Nishi-ku, Sapporo, Hokkaido 063-0811, Japan.
Received: 22 January 2015 Accepted: 28 May 2015
References
1. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV. Image-guided oncologic
surgery using invisible light: completed pre-clinical development for sentinel
lymph node mapping. Ann Surg Oncol. 2006;13:1671–81.
2. Kitai T, Inamoto T, Miwa M, Shikayama T. Fluorescence navigation with
indocyanine green for detecting sentinel lymph nodes in breast cancer
patients. Breast Cancer. 2005;12:211–5.
3. Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M, Miwa M. Sentinel
node mapping guided by indocyanine green fluorescence imaging: a new
method for sentinel node navigation surgery in gastrointestinal cancer. Dig
Surg. 2008;25:103–8.
4. Tajima Y, Yamazaki K, Masuda Y, Kato M, Yasuda D, Aoki T, et al. Sentinel
node mapping guided by indocyanine green fluorescence imaging in
gastric cancer. Ann Surg. 2009;249:58–62.
5. Parungo CP, Ohnishi S, Kimu SW, Kim S, Laurence RG, Soltesz EG, et al.
Intraoperative identification of esophageal sentinel lymph nodes with
near-infrared fluorescence imaging. J Thorac Cardiovasc Surg. 2005;129:844–50.
6. Rubens FD, Ruel M, Fremes SE. A new and simplified method for coronary
and graft imaging during CABG. Heart Surg Forum. 2002;5:141–4.
7. Aoki T, Yasuda D, Shimizu Y, Odaira M, Niiya T, Kusano T, et al. Image-guided
liver mapping using fluorescence navigation system with indocyanine green
for anatomical hepatic resection. World J Surg. 2008;32:1763–7.
8. Uchiyama K, Ueno M, Ozawa S, Kiriyama S, Shigekawa Y, Hirono S, et al.
Combined intraoperative use of contrast-enhanced ultrasonography
imaging using a sonazoid and fluorescence navigation system with
indocyanine green during anatomical hepatectomy. Langenbecks
Arch Surg. 2011;396:1101–7.
9. Ishizawa T, Tamura S, Masuda K, Aoki T, Hasegawa K, Imamura H, et al.
Intraoperative fluorescent cholangiography using indocyanine green:
a biliary road map for safe surgery. J Am Coll Surg. 2009;208:e1–4.
10. Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al.
Real-time identification of liver cancers by using indocyanine green
fluorescent imaging. Cancer. 2009;115:2491–504.
11. Morita Y, Sakaguchi T, Unno N, Shibasaki Y, Suzuki A, Fukumoto K, et al.
Detection of hepatocellular carcinomas with near-infrared fluorescence
imaging using indocyanine green: its usefulness and limitation. Int J Clin
Oncol. 2013;18:232–41.
12. Yokoyama N, Otani T, Hashidate H, Maeda C, Katada T, Sudo N, et al.
Real-time detection of hepatic micrometastases from pancreatic cancer by
intraoperative fluorescence imaging. Cancer. 2012;118:2813–9.
13. van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ,
Hartgrink HH, et al. Near-infrared fluorescence-guided resection of colorectal
liver metastases. Cancer. 2013;119:3411–8.
14. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A
16-year experience in performing hepatic resection in 303 patients with
hepatocellular carcinoma. Surgery. 2002;131:s153–8.
15. Yaseen MA, Yu J, Wong MS, Anvari B. In-vivo fluorescence imaging of
mammalian organs using charge-assembled mesocapsule constructs
containing indocyanine green. Opt Express. 2008;16:20577–87.
Shimada et al. World Journal of Surgical Oncology  (2015) 13:198 Page 9 of 916. Sakaguchi T, Suzuki A, Unno N, Morita Y, Oishi K, Fukumoto K, et al. Bile leak
test by indocyanine green fluorescence images after hepatectomy. Am J
Surg. 2010;200:e19–23.
17. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Intraoperative indocyanine green
fluorescent imaging for prevention of bile leakage after hepatic resection.
Surgery. 2011;150:91–8.
18. Kawaguchi Y, Sugawara Y, Ishizawa T, Satou S, Kaneko J, Tamura S, et al.
Identification of veno-occlusive regions in a right liver graft after
reconstruction of vein segments 5 and 8: application of indocyanine
green fluorescence imaging. Liver Transpl. 2013;19:778–9.
19. Kubota K, Kita J, Shimoda M, Rokkaku K, Kato M, Iso Y. Intraoperative
assessment of reconstructed vessels in living-donor liver transplantation,
using a novel fluorescence imaging technique. J Hepatobiliary Pancreat
Surg. 2006;13:100–4.
20. Stieger B, Heger M, Graaf W, Paumgartner G, Gulik T. The emerging role of
transport systems in liver function tests. Eur J Pharmacol. 2012;675:1–5.
21. Sathirakul K, Suzuki H, Yasuda K, Hanano M, Tagaya O, Horie T, et al. Kinetic
analysis of hepatobiliary transport of organic anions in Eisai
hyperbilirubinemic mutant rats. J Pharmacol Exp Ther. 1993;265:1301–12.
22. Ishizawa T, Masuda K, Urano Y, Kawaguchi Y, Satou S, Kaneko J, et al.
Mechanistic background and clinical applications of indocyanine green
fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol.
2014;21:440–8.
23. Tanaka T, Takatsuki M, Hidaka M, Hara T, Muraoka I, Soyama A, et al. Is a
fluorescence navigation system with indocyanine green effective enough to
detect liver malignancies? J Hepatobiliary Pancreat Surg. 2014;21:199–204.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
